Ask AI
VIVID 3
VIVID 3: Phase I/II Study of VGA039, a Novel Protein S Antibody, as Maintenance Therapy in Patients With von Willebrand Disease

Released: December 15, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 15, 2025